Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Medical House was a specialized medical technology company focused on the design and development of innovative drug delivery systems. The company was best known for its range of needle-free injectors and auto-injectors, including the Auto-Safety Injector (ASI) platform. These technologies were designed to improve patient compliance and safety for self-administration of injectable drugs. The company's products were utilized across various therapeutic areas such as diabetes and growth hormone therapy. In 2009, the company was acquired by Consort Medical to bolster its Bespak drug delivery division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Medical House.